United States of America: Moderna is awarded $144.1 million in support of the COVID-19 vaccine development for pediatric population, aged between six months to 12 years old

Back to state act

Description

On 15 June 2021, Biomedical Advanced Research and Development Authority (BARDA) announced collaborating with Moderna Inc for the development of the COVID-19 vaccine (the SARS-CoV-2 mRNA-1273) to inclu...

Intervention Details

Intervention Type

State aid, unspecified

MAST Chapter

L: Subsidies (excl. export subsidies)

Implementation date

15 Jun 2021

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Affected Products

Threads

See all

This intervention is not part of any Thread yet.